Jorge Alberto Bernal Mesa, Md, Evelyn Astrid Dorado Alban, Md. Americas Clinic Ces University
Esophageal cancer is a rare disease with aggressive behavior and high mortality to 5 years. The prognosis depends on clinical status at the time of diagnosis and 70 to 80% have nodal commitment and survival to a pathological condition after surgery
It was reported that only 25% are candidates for curative resection
Surgery and adjuvant are the options in these patients. Reports since 1992 of combined techniques in minimal invasive techniques esophagectomy
You have two types of approaches: transhiatal and three fields: thoracoscopy, laparoscopy and cervicotomy.
Describe the surgical technique of gastric ascent and endoscopy esophagectomy and perioperative morbidity.
MATERIAL AND METHODS:
retrospective study, descriptive. It took a sample of nine cases performed from January to July 2010 at the Clinica Las Americas.
1. Resectable esophageal cancer staging by studies
2. Surgery performed by the group investigated
2. Criteria for inoperable or metastatic disease
100% were men between 55 and 76.
two received neoadjuvant chemotherapy and radiotherapy.
Lymphadenectomy was performed by thoracoscopic esophagectomy with posterior approach and then lymphadenectomy was done on the lesser curvature of the stomach and tubulization laparoscopy.
The specimen was removed through a cervical esophagogastric anastomosis left and laterolateral with linear stapler.
Surgical time: 340 minutes, blood loss 150 cc
They moved to ICU extubated on the second day.
Complications: 3 patients: 2 patients recurrent laryngeal nerve paresis 1 patient ventilator-associated pneumonia. No patient filter or died.
The pathology showed invasive adenocarcinomas, free edges, average 25 nodes removed.
Esophageal cancer is a rare disease, few patients are surgical. The rise Gastric video is a procedure done that merits little advanced training. We want to show the benefit of the procedure which is summarized in good tolerance, oncological radical, low morbidity without mortality.
Program Number: P244